This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Eisai R&D Management Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Victoria Rimkunas: Inventor in Cancer Therapy
Introduction
Victoria Rimkunas is an inventor associated with Reading, Massachusetts, and pharmaceutical research at Eisai R&D Management Co., Ltd. Her patent work concerns an oral dosage form of an estrogen receptor-alpha (ERα) inhibitor for cancer treatment.
Latest Patents
Rimkunas is listed as an inventor on one patent, titled “Method for Treating Cancer with an Oral Dosage Form of an Estrogen Receptor-Alpha Inhibitor.” The invention describes pharmaceutical compositions containing an inhibitor of human ERα and methods for using the inhibitor in cancer therapy. It focuses on dosages of H3B-6545 with defined pharmacokinetic profiles intended to support effective and safe administration to patients.
Career Highlights
Rimkunas’s listed patent reflects work at the intersection of pharmaceutical development and cancer treatment. The disclosed approach addresses how an ERα inhibitor may be formulated and dosed for human use.
Collaborations
Her listed coworkers include Jianjun Xiao and Nathalie M. Rioux. The patent’s subject matter reflects collaborative research and development in pharmaceutical therapy.
Conclusion
Victoria Rimkunas’s patent contribution focuses on the dosing and use of H3B-6545, an ERα inhibitor investigated for cancer therapy, and represents her documented work in pharmaceutical innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile